Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 6Phase NA 2Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 1061Neoplasms 887Prostatic Neoplasms 513Lung Neoplasms 426Colorectal Neoplasms 360Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 176Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 137Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Glioblastoma 87Endometrial Neoplasms 87Disease 85Lymphoma 84Sarcoma 78

Interventions

Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Adrenocortical Carcinoma × 1 year × Clear all
NCT06141369 2026-04-09

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Shanghai Jiao Tong University School of Medicine

Phase NA Recruiting
21 enrolled
Endocrine

Adenoma, Islet Cell, Adrenocortical Carcinoma, Carcinoma, Medullary

NCT07141147 2025-09-03

A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.

Sun Yat-sen University

Phase NA Not yet recruiting
58 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡